Majid, Baby Boy .

HRN: 25-60-17  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/31/2024
AMPICILLIN 250MG (VIAL)
08/31/2024
09/06/2024
IV
50mg
Q12h
PSNB
Waiting Final Action 
08/31/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/31/2024
09/06/2024
IV
15mg
OD
PSNB
Waiting Final Action 
09/02/2024
CEFOTAXIME 500MG (VIAL)
09/02/2024
09/09/2024
IV
50 Mg
Q12 Hrs
Neonatal Sepsis
Waiting Final Action 
09/05/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/05/2024
09/12/2024
IV
75mg
Q6h
PSNB
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: